UGT1A1 genotyping for irinotecan-based chemotherapy in the first-line treatment for metastatic colorectal cancer patients with hyperbilirubinemia: Report of cases
Biomarkers and Genomic Medicine · 2013
DOI: 10.1016/j.bgm.2013.08.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomarkers and Genomic Medicine, 2013. Verfasst von Yung-Sung Yeh und 6 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Yeh, Y., Wu, M., Huang, M., Chang, S., Chen, C., Hu, H., & Wang, J. (2013). UGT1A1 genotyping for irinotecan-based chemotherapy in the first-line treatment for metastatic colorectal cancer patients with hyperbilirubinemia: Report of cases. Biomarkers and Genomic Medicine. https://doi.org/10.1016/j.bgm.2013.08.005
Vancouver
Yeh Y, Wu M, Huang M, Chang S, Chen C, Hu H, et al. UGT1A1 genotyping for irinotecan-based chemotherapy in the first-line treatment for metastatic colorectal cancer patients with hyperbilirubinemia: Report of cases. Biomarkers and Genomic Medicine. 2013. doi:10.1016/j.bgm.2013.08.005
BibTeX
@article{Yeh2013,
author = {Yeh, Yung-Sung and Wu, Ming-Xia and Huang, Meng-Lin and Chang, Se-Fen and Chen, Chin-Fan and Hu, Huang-Ming and Wang, Jaw-Yuan},
title = {UGT1A1 genotyping for irinotecan-based chemotherapy in the first-line treatment for metastatic colorectal cancer patients with hyperbilirubinemia: Report of cases},
journal = {Biomarkers and Genomic Medicine},
year = {2013},
doi = {10.1016/j.bgm.2013.08.005}
}
EUVIMED